TREMFYA

( DrugBank: - / KEGG DRUG: - )

2 diseases

ID	Disease name (Link within this page)	Number of trials
37	Generalised pustular psoriasis	5

ID	Disease name (Link within this page)	Number of trials
97	Ulcerative colitis	2

37. Generalised pustular psoriasis

Clinical trials : 79 / Drugs : 57 - (DrugBank : 21) / Drug target genes : 20 - Drug target pathways : 102

trials per page:

Showing 1 to 5 of 5 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-003206-58-GB (EUCTR)	29/07/2019	28/05/2019	A Clinical Study to Evaluate the Efficacy and Safety of Guselkumab for the Treatment of Palmoplantar ...	A Phase 3b, Multicenter, Interventional, Randomized, Placebo controlled Study Investigating the Effi ...	Palmoplantar non-Pustular Psoriasis MedDRA version: 20.0;Level: PT;Classification code 10037153;Term ...	Trade Name: TREMFYA® Product Name: Guselkumab Product Code: CNTO1959 INN or Proposed INN: GUSELKUMAB Oth ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	105	Phase 3	France;Spain;Germany;United Kingdom
2	EUCTR2018-003206-58-IT (EUCTR)	11/07/2019	15/06/2021	A Clinical Study to Evaluate the Efficacy and Safety of Guselkumab for the Treatment of Palmoplantar ...	A Phase 3b, Multicenter, Interventional, Randomized, Placebo controlled Study Investigating the Effi ...	Palmoplantar non-Pustular Psoriasis MedDRA version: 20.0;Level: PT;Classification code 10037153;Term ...	Trade Name: TREMFYA Product Name: GUSELKUMAB Product Code: [CNTO1959] INN or Proposed INN: GUSELKUMAB Ot ...	JANSSEN CILAG INTERNATIONAL NV	NULL	Not Recruiting	Female: yes Male: yes	105	Phase 3	France;Spain;Germany;United Kingdom;Italy
3	EUCTR2018-003206-58-DE (EUCTR)	02/07/2019	25/04/2019	A Clinical Study to Evaluate the Efficacy and Safety of Guselkumab for the Treatment of Palmoplantar ...	A Phase 3b, Multicenter, Interventional, Randomized, Placebo controlled Study Investigating the Effi ...	Palmoplantar non-Pustular Psoriasis MedDRA version: 20.0;Level: PT;Classification code 10037153;Term ...	Trade Name: TREMFYA® Product Name: Guselkumab Product Code: CNTO1959 INN or Proposed INN: GUSELKUMAB Oth ...	Janssen-Cilag International N.V.	NULL	Not Recruiting	Female: yes Male: yes	105	Phase 3	France;Spain;Germany;Italy;United Kingdom
4	EUCTR2018-003206-58-FR (EUCTR)	29/06/2019	11/04/2019	A Clinical Study to Evaluate the Efficacy and Safety of Guselkumab for the Treatment of Palmoplantar ...	A Phase 3b, Multicenter, Interventional, Randomized, Placebo controlled Study Investigating the Effi ...	Palmoplantar non-Pustular Psoriasis MedDRA version: 20.0;Level: PT;Classification code 10037153;Term ...	Trade Name: TREMFYA® Product Name: Guselkumab Product Code: CNTO1959 INN or Proposed INN: GUSELKUMAB Oth ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	105	Phase 3	France;Spain;Germany;United Kingdom
5	EUCTR2018-003206-58-ES (EUCTR)	20/06/2019	08/05/2019	A Clinical Study to Evaluate the Efficacy and Safety of Guselkumab for the Treatment of Palmoplantar ...	A Phase 3b, Multicenter, Interventional, Randomized, Placebo controlled Study Investigating the Effi ...	Palmoplantar non-Pustular Psoriasis MedDRA version: 20.0;Level: PT;Classification code 10037153;Term ...	Trade Name: TREMFYA® Product Name: Guselkumab Product Code: CNTO1959 INN or Proposed INN: GUSELKUMAB Oth ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	105	Phase 3	France;Spain;Germany;United Kingdom

First Previous1Next Last

97. Ulcerative colitis

Clinical trials : 2,630 / Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-001510-15-DE (EUCTR)	02/05/2019	19/11/2018	A Proof-of-concept Study of the Efficacy and Safety of Combination Therapy With Guselkumab and Golim ...	A Phase 2a Randomized, Double-blind, Active-controlled, Parallel-group, Multicenter, Proof-of-concep ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Guselkumab Product Code: CNTO1959 INN or Proposed INN: Guselkumab Trade Name: TREMFYA® Pro ...	Janssen-Cilag International NV	NULL	Not Recruiting			Female: yes Male: yes	210	Phase 2	United States;Mexico;Argentina;Poland;Brazil;Ukraine;Australia;Russian Federation;Germany
2	EUCTR2018-001510-15-PL (EUCTR)	01/03/2019	04/02/2019	A Proof-of-concept Study of the Efficacy and Safety of Combination Therapy With Guselkumab and Golim ...	A Phase 2a Randomized, Double-blind, Active-controlled, Parallel-group, Multicenter, Proof-of-concep ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Guselkumab Product Code: CNTO1959 INN or Proposed INN: Guselkumab Trade Name: TREMFYA® Pro ...	Janssen-Cilag International NV	NULL	Not Recruiting			Female: yes Male: yes	210	Phase 2	United States;Mexico;Argentina;Brazil;Poland;Ukraine;Australia;Russian Federation;Germany

First Previous1Next Last